Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.52)
# 863
Out of 5,072 analysts
529
Total ratings
41.47%
Success rate
7.07%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $26.35 | +21.44% | 4 | Nov 24, 2025 | |
| BNGO Bionano Genomics | Maintains: Buy | $11 → $7 | $1.68 | +316.67% | 3 | Nov 24, 2025 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $3.65 | +146.58% | 21 | Nov 24, 2025 | |
| CODX Co-Diagnostics | Reiterates: Neutral | n/a | $0.33 | - | 24 | Nov 24, 2025 | |
| LFMD LifeMD | Maintains: Buy | $13 → $9 | $3.97 | +126.70% | 11 | Nov 19, 2025 | |
| VNRX VolitionRx | Maintains: Buy | $2.5 → $1.5 | $0.33 | +351.81% | 4 | Nov 17, 2025 | |
| VVOS Vivos Therapeutics | Initiates: Buy | $7 | $2.15 | +225.58% | 1 | Nov 17, 2025 | |
| BRNS Barinthus Biotherapeutics | Maintains: Buy | $3 → $4 | $0.70 | +470.37% | 14 | Nov 17, 2025 | |
| SMTI Sanara MedTech | Maintains: Buy | $54 → $36 | $19.70 | +82.74% | 6 | Nov 14, 2025 | |
| LPCN Lipocine | Maintains: Buy | $8 → $7 | $3.25 | +115.38% | 5 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $39.00 | +76.92% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $19.27 | +117.96% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $76.06 | +17.01% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.74 | +188.13% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $15.45 | +10.03% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $26 | $28.39 | -8.42% | 2 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $12.10 | +57.02% | 28 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.71 | +250.34% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $12.23 | +178.00% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.62 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.06 | +239.81% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $98 | $136.05 | -27.97% | 21 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.35 | +60.92% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.84 | +106.61% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.82 | +449.45% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.32 | +203.03% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.61 | +459.01% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.02 | +99.00% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $14.39 | +59.80% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.73 | - | 24 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.06 | +277.36% | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $0.90 | +8,234.26% | 22 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $12.30 | +30.08% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $16.26 | +10.70% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $17.96 | +39.20% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $7.85 | +396.82% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.30 | +130.77% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.38 | +688.23% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.34 | +1,182.05% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.96 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $2.80 | +17,757.14% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.18 | +6,011.11% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.45 | - | 7 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $10.73 | +347.34% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $101.15 | -81.22% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.94 | - | 2 | Apr 16, 2020 |
BioLife Solutions
Nov 24, 2025
Reiterates: Buy
Price Target: $32
Current: $26.35
Upside: +21.44%
Bionano Genomics
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.68
Upside: +316.67%
Alpha Tau Medical
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $3.65
Upside: +146.58%
Co-Diagnostics
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.33
Upside: -
LifeMD
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.97
Upside: +126.70%
VolitionRx
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.33
Upside: +351.81%
Vivos Therapeutics
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $2.15
Upside: +225.58%
Barinthus Biotherapeutics
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.70
Upside: +470.37%
Sanara MedTech
Nov 14, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $19.70
Upside: +82.74%
Lipocine
Nov 13, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.25
Upside: +115.38%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $39.00
Upside: +76.92%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $19.27
Upside: +117.96%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $76.06
Upside: +17.01%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.74
Upside: +188.13%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $15.45
Upside: +10.03%
Oct 30, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $28.39
Upside: -8.42%
Oct 8, 2025
Maintains: Buy
Price Target: $15 → $19
Current: $12.10
Upside: +57.02%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.71
Upside: +250.34%
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $12.23
Upside: +178.00%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.62
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.06
Upside: +239.81%
Sep 15, 2025
Maintains: Buy
Price Target: $100 → $98
Current: $136.05
Upside: -27.97%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $4.35
Upside: +60.92%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.84
Upside: +106.61%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $1.82
Upside: +449.45%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.32
Upside: +203.03%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $1.61
Upside: +459.01%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.02
Upside: +99.00%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $14.39
Upside: +59.80%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.73
Upside: -
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.06
Upside: +277.36%
Jul 18, 2025
Downgrades: Neutral
Price Target: $75
Current: $0.90
Upside: +8,234.26%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $12.30
Upside: +30.08%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $16.26
Upside: +10.70%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $17.96
Upside: +39.20%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $7.85
Upside: +396.82%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.30
Upside: +130.77%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.38
Upside: +688.23%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.34
Upside: +1,182.05%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.96
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $2.80
Upside: +17,757.14%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.18
Upside: +6,011.11%
Jun 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.45
Upside: -
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $10.73
Upside: +347.34%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $101.15
Upside: -81.22%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.94
Upside: -